Brexgyl-D Syrup

Introduction

Brexgyl-D is a prescription medication that contains three active ingredients: Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine. It is commonly prescribed to relieve symptoms associated with the common cold, allergies, and respiratory tract infections.

Uses

Brexgyl-D is indicated for the temporary relief of symptoms such as nasal congestion, cough, runny nose, and sneezing caused by the common cold, allergies, or respiratory tract infections. It helps to alleviate these symptoms by reducing nasal congestion, suppressing cough, and relieving sinus pressure.

Dosage and Administration

Dosing Instructions: The recommended dosage for adults and children 12 years and older is 10 mL (2 teaspoons) every 4 to 6 hours as needed. Do not exceed 6 doses (60 mL) in 24 hours.

For children 6 to 12 years old, the recommended dosage is 5 mL (1 teaspoon) every 4 to 6 hours as needed. Do not exceed 6 doses (30 mL) in 24 hours.

Administer the syrup orally, using the provided measuring device to ensure accurate dosing. Shake the bottle well before each use. Follow the instructions provided by your healthcare professional or the product label.

Mechanism of Action

Brexgyl-D contains three active ingredients that work together to relieve symptoms associated with the common cold and allergies.

• Chlorpheniramine Maleate is an antihistamine that blocks the effects of histamine, a substance in the body that causes allergy symptoms.
• Dextromethorphan Hydrobromide is a cough suppressant that works by reducing the urge to cough.
• Phenylephrine is a nasal decongestant that helps to shrink blood vessels in the nasal passages, reducing congestion and improving breathing.

By targeting these different aspects of cold and allergy symptoms, Brexgyl-D provides effective relief.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. These side effects are usually mild and may go away on their own. If any of these side effects persist or worsen, consult your healthcare professional.

In rare cases, Brexgyl-D may cause serious side effects such as allergic reactions, rapid heart rate, high blood pressure, difficulty urinating, or severe dizziness. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Brexgyl-D may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and other medications that affect the central nervous system. These interactions can increase the risk of side effects or reduce the effectiveness of the medications. Inform your healthcare professional about all the medications you are currently taking to avoid potential drug interactions.

Precautions

Before using Brexgyl-D, inform your healthcare professional if you have any pre-existing medical conditions, such as diabetes, high blood pressure, heart problems, thyroid disorders, or urinary retention. Additionally, inform them of any allergies or sensitivities you may have to medications or other substances.

Brexgyl-D should not be used in children under 6 years old without the guidance of a healthcare professional. Follow the recommended dosage and not exceed the maximum daily dose.

Avoid consuming alcohol or operating machinery while taking Brexgyl-D, as it may cause drowsiness or dizziness.

Storage

Store Brexgyl-D at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use. Do not freeze the medication. Keep it out of the reach of children and pets.

Patient Tips

• Follow the dosing instructions provided by your healthcare professional or as indicated on the product label. Do not exceed the recommended dosage.
• If your symptoms persist or worsen, or if new symptoms develop, consult your healthcare professional.
• Avoid taking other medications that contain the same active ingredients as Brexgyl-D, as this may result in an overdose.
• Maintain proper hydration by drinking plenty of fluids while using Brexgyl-D.
• If you have any concerns or questions about Brexgyl-D, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Chlorphenamine: drowsy (sedating) antihistamine (NHS UK) [Accessed 29 Jun. 2024] (online) Available at:
• Benylin Dry Coughs (Original) (Health Professionals SmPC) Available at:
• Chlorpheniramine (Drugs.com) [Accessed 27 Jun. 2024] (online) Available at:
• chlorpheniramine maleate (OTC) [Accessed 11 Jun. 2024] (online) Available at:
• Codeine (MedlinePlus) [Accessed 21 Jun. 2024] (online) Available at:
• Kumar M, Upadhayay P, Shankar R, Joshi M, Bhatt S, Malik A. Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis. Drug Deliv Transl Res. 2019 Dec;9(6):1017-1026. doi: 10.1007/s13346-019-00639-w. [Accessed 13 Jun. 2024] Available at: